SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-13-006062
Filing Date
2013-11-05
Accepted
2013-11-05 08:08:52
Documents
24
Period of Report
2013-11-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k110113_soligenix.htm 8-K 27561
2 ORAL MUCOSITIS - ADVANCING THE NEXT GENERATION OF THERAPIES PRESENTATION. f8k110113ex99i_soligenix.htm EX-99.1 17563
3 img01.jpg GRAPHIC 161558
4 img02.jpg GRAPHIC 312805
5 img03.jpg GRAPHIC 224651
6 img04.jpg GRAPHIC 228253
7 img05.jpg GRAPHIC 230027
8 img06.jpg GRAPHIC 206224
9 img07.jpg GRAPHIC 152063
10 img08.jpg GRAPHIC 164327
11 img09.jpg GRAPHIC 229302
12 img10.jpg GRAPHIC 257630
13 img11.jpg GRAPHIC 256215
14 img12.jpg GRAPHIC 294813
15 img13.jpg GRAPHIC 306237
16 img14.jpg GRAPHIC 45154
17 img15.jpg GRAPHIC 172773
18 img16.jpg GRAPHIC 224186
19 img17.jpg GRAPHIC 318712
20 img18.jpg GRAPHIC 245243
21 img19.jpg GRAPHIC 212441
22 img20.jpg GRAPHIC 235439
23 img21.jpg GRAPHIC 221803
24 img22.jpg GRAPHIC 309936
  Complete submission text file 0001213900-13-006062.txt   6951374
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 131190906
SIC: 2834 Pharmaceutical Preparations